Tempest Registers 9.5M Warrant Shares for Resale, Potential $5.2M Proceeds
TPST is trading near its 52-week low of $0.743 (9.1% above the low).
Summary
Tempest Therapeutics registered 9.53 million warrant shares for resale, potentially raising $5.22 million if all warrants are exercised for cash. The registration makes the shares tradable, adding selling pressure to a stock already under $1.
Key Events · Financing and Capital Events · TPST
-
9.53M Warrant Shares Registered for Resale
Registration covers 3.11M pre-funded warrant shares, 3.11M Series C warrant shares, 3.11M Series D warrant shares, and 217,391 placement agent warrant shares.
-
Potential $5.22M Proceeds from Warrant Exercise
If all warrants are exercised for cash, gross proceeds would be approximately $5.22 million. Pre-funded warrants are exercisable at $0.001, common warrants at $0.805, and placement agent warrants at $1.0063.
-
Dilution Risk from Full Exercise
Outstanding shares would increase from 16.89 million to 26.42 million if all warrants are exercised, a 56% increase in share count.
-
Placement Agent Compensation
H.C. Wainwright received a 7.0% cash fee on gross proceeds plus placement agent warrants for 217,391 shares.
Analysis · TPST · Life Sciences
Tempest Therapeutics has registered for resale up to 9.53 million shares underlying warrants issued in its September 11 private placement. The registration makes these shares tradable, creating potential selling pressure on a stock already trading near $0.81. If all warrants are exercised for cash, the company would receive approximately $5.22 million — meaningful liquidity for a company that reported only $0.8 million in cash as of August 13, 2026. The common warrants carry a $0.805 exercise price, roughly in line with the current market price, while the pre-funded warrants are exercisable at $0.001. The placement agent received a 7.0% cash fee, and the deal includes standard 4.99%/9.99% beneficial ownership blockers. Against the backdrop of a going-concern warning and repeated capital raises, this registration is part of an ongoing survival financing pattern.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 29.7% of the 1531 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TPST was trading at $0.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.7M. The 52-week trading range was $0.74 to $12.23. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.